Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes. - El-Khateeb E; Khrieba MO; Badawoud AM; Morsy AA; El-Hanafy AA; Hamza E; Habba E; El-Hanafy DA; Eltantawy N; Al-Dhelaan RA; Radwan KH; El-Sayed AA; et al. (Naunyn-Schmiedeberg's archives of pharmacology, 2026)